Diabetes Therapy
Research add new data to diabetes therapy body of knowledge
Published in Blood Weekly, December 29th, 2005
Study 1: Patients with nonalcoholic steatohepatitis (NASH) and type 2 diabetes benefit from nateglinide.
"In the present study we administered nateglinide to NASH patients with type 2 diabetes who had failed to respond adequately to diet and exercise therapy, and we compared the resulting changes in insulin kinetics and improvements in blood glucose levels, as well as the concomitant changes in hepatic function, diagnostic liver images and liver histology, with the results from a non-treated control group," investigators in Japan report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-12-29)
More Articles from Blood Weekly
- Blood Banking
Blood stored at 4 degrees C has less immunomodulatory changes than blood kept at room temperature - Blood Exposure
Human bites and blood exposures in New York City schools have potential for serious outcomes - Blood Safety
Blood safety can be evaluated by modeling risks of viral transmission - Stem Cell Transplantation
Ionizing radiation enhances transplanted multipotent astrocytic stem cell engraftment - Angiology
Ultrasonography measures increased carotid artery intima-media thickness in Behcet disease - Antisense Technology
Promoter hypomethylation marks the progression of chronic myeloid leukemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
